MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

Search

Integra LifeSciences Holdings Corp

Chiusa

SettoreSettore sanitario

12.41 -1.74

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

12.31

Massimo

12.62

Metriche Chiave

By Trading Economics

Entrata

479M

-5.4M

Vendite

-14M

402M

Margine di Profitto

-1.344

Dipendenti

4,396

EBITDA

526M

54M

Raccomandazioni

By TipRanks

Raccomandazioni

Vendi

Previsioni per 12 mesi

-1.6% downside

Dividendi

By Dow Jones

Utili prossimi

24 feb 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-231M

1B

Apertura precedente

14.15

Chiusura precedente

12.41

Notizie sul Sentiment di mercato

By Acuity

40%

60%

129 / 361 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

16 gen 2026, 23:29 UTC

Azioni calde

Stocks to Watch: Atossa Therapeutics, Union Pacific

16 gen 2026, 22:48 UTC

Acquisizioni, Fusioni, Takeovers

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- 2nd Update

16 gen 2026, 22:43 UTC

Acquisizioni, Fusioni, Takeovers

Union Pacific: Additional Information Requested to Be Provided to Surface Transportation Board

16 gen 2026, 22:22 UTC

Acquisizioni, Fusioni, Takeovers

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- Update

16 gen 2026, 21:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Tech, Media & Telecom Roundup: Market Talk

16 gen 2026, 21:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Auto & Transport Roundup: Market Talk

16 gen 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

16 gen 2026, 21:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

16 gen 2026, 21:48 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Union Pacific, Norfolk Southern Market Share Ruled as Faulty -- Market Talk

16 gen 2026, 21:41 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Union Pacific, Norfolk Southern Deal Rejection Leaves Questions -- Market Talk

16 gen 2026, 21:38 UTC

Acquisizioni, Fusioni, Takeovers

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- WSJ

16 gen 2026, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

STB: Union Pacific, Norfolk Southern Application Doesn't Include 'Projected Market Shares' as Required

16 gen 2026, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

STB: Union Pacific, Norfolk Southern Application Doesn't Include Certain Schedules, Documents Expressly Made Part of Merger Agreement

16 gen 2026, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

STB: Union Pacific, Norfolk Southern Application Doesn't Contain Certain Information Required by Regulations

16 gen 2026, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

STB: Application Rejected Without Prejudice to Union Pacific, Norfolk Southern Refiling Revised Application Remedying Deficiencies

16 gen 2026, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

Surface Transportation Board: Union Pacific, Norfolk Southern Major Merger Application Filed Dec. 19 Incomplete

16 gen 2026, 20:44 UTC

Utili

5 Takeaways From This Season's Wealth Management Earnings -- Barrons.com

16 gen 2026, 20:42 UTC

Discorsi di Mercato

Oil Futures Post Fourth Straight Weekly Gain -- Market Talk

16 gen 2026, 20:28 UTC

Discorsi di Mercato

U.S. Natural Gas Slips Ahead of Long Weekend -- Market Talk

16 gen 2026, 19:12 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Netflix Could Comment on Structure of Warner Bid During 4Q Results -- Market Talk

16 gen 2026, 18:53 UTC

Discorsi di Mercato

Global Crude Supply Enough to Absorb Any Iran Disruption -- Market Talk

16 gen 2026, 18:41 UTC

Discorsi di Mercato

Netflix's Ad Business Seen as Primary Revenue Driver in 2026 -- Market Talk

16 gen 2026, 18:31 UTC

Discorsi di Mercato

U.S. Oil Rig Count Rises By 1 to 410 -- Market Talk

16 gen 2026, 17:20 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

16 gen 2026, 17:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

16 gen 2026, 17:20 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

16 gen 2026, 17:03 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

16 gen 2026, 17:03 UTC

Discorsi di Mercato

All Eyes on Guidance for European Big Pharma Earnings Season -- Market Talk

16 gen 2026, 16:32 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Sanofi Needs Dealmaking to Offset Pipeline Disappointments -- Market Talk

16 gen 2026, 16:20 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

Integra LifeSciences Holdings Corp Previsione

Obiettivo di Prezzo

By TipRanks

-1.6% in calo

Previsioni per 12 mesi

Media 12.33 USD  -1.6%

Alto 14 USD

Basso 10 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Integra LifeSciences Holdings Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Vendi

6 ratings

0

Acquista

2

Mantieni

4

Vendi

Punteggio Tecnico

By Trading Central

12.75 / 16.41Supporto e resistenza

A breve termine

Strong Bearish Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

Weak Bearish Evidence

Sentiment

By Acuity

129 / 361 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat